Results 61 to 70 of about 136,011 (340)
Liver Cancer, 2021 Introduction: Atezolizumab-bevacizumab is the new standard of care for first-line treatment of advanced hepatocellular carcinoma (HCC). However, the optimal sequence of therapy after disease progression on atezolizumab-bevacizumab is unclear.
C. Yoo +12 more
semanticscholar +1 more source
Cancer Medicine, 2020 Introduction Bevacizumab has demonstrated activity in glioblastoma (GBM), but the true benefits and optimal dose‐schedule are debated. A lower dose‐schedule than standard‐dose bevacizumab (10 mg/kg 2‐weekly) might offer similar benefits with lower costs.
Jack Patrick Gleeson +13 more
doaj +1 more source
MDM Policy & Practice, 2021 Background. Real-world evidence can be a valuable tool when clinical trial data are incomplete or uncertain. Bevacizumab was adopted as first-line therapy for metastatic colorectal cancer (mCRC) based on significant survival improvements in initial ...
Reka E. Pataky +11 more
doaj +1 more source
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
New England Journal of Medicine, 2011 BACKGROUND Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data ...
Daniel F. Martin +5 more
semanticscholar +1 more source
Liver Cancer, 2021 Introduction: Atezolizumab plus bevacizumab significantly improved overall survival (OS) and progression-free survival (PFS) versus sorafenib in patients with unresectable hepatocellular carcinoma (HCC) in IMbrave150.
S. Qin +14 more
semanticscholar +1 more source
Adverse events associated with intraocular injection of anti-VEGF(bevacizumab) in retinal vein ccclusion: a case report [PDF]
, 2015 Introduction: Antiangiogenic agents are often administered for treatment of Branch Retinal Vein Occlusion (BRVO). Among them, Bevacizumab has noticeable antiangiogenic and antiedemigenic properties and possesses great capacity to penetrate the retinal ...
ARTICO, Marco +7 more
core +1 more source
Bevacizumab and corneal pathology
Medicina fluminensis, 2017 Cilj rada je dati pregled postojeće literature o terapiji bevacizumabom u liječenju neovaskularnih poremećaja rožnice. Rožnica je jedinstveno tkivo zbog svoje prirodne avaskularnosti. Imunoprivilegirano je vezivno tkivo koje služi kao mehanička prepreka i prednja refraktivna površina oka.
Bilen Babić, Marijana, Merlak, Maja
openaire +4 more sources
Macromolecular Bioscience, Volume 22, Issue 12, December 2022., 2022 To accelerate biodegradation of stable poly(ethylene glycol)‐based hydrogels cross‐linked via the rapid inverse electron demand Diels–Alder reaction between norbornene and tetrazine groups, 3,6‐epoxy‐1,2,3,6‐tetrahydrophthalimide, phenyl carbamate, carbonate ester, and phenyl carbonate ester are synthesized into the hydrogel backbone.
Christian E. Ziegler +3 more
wiley +1 more source
A Fokker-Planck feedback control framework for optimal personalized therapies in colon cancer-induced angiogenesis [PDF]
arXiv, 2021 In this paper, a new framework for obtaining personalized optimal treatment strategies in colon cancer-induced angiogenesis is presented. The dynamics of colon cancer is given by a It\'o stochastic process, which helps in modeling the randomness present in the system.
arxiv
European medicines agency approval summary: zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer [PDF]
, 2017 On 1 February 2013, a marketing authorisation valid throughout the European Union was issued for aflibercept (Zaltrap) in combination with irinotecan/5-fluorouracil/ folinic acid chemotherapy for the treatment of adults with metastatic colorectal cancer ...
Caleno, Mariapaola +8 more
core +1 more source